Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00418730
Status:
COMPLETED
Last Update Posted:
2008-05-20
First Post:
2007-01-03
Brief Title:
Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Sponsor:
Neosil Inc
Organization:
Neosil Inc
Study Overview
Official Title:
A Phase 2 Multicenter Randomized Placebo- and Comparator-Controlled Double-Blind Parallel Group Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopecia in Men
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to measure the hair growth response to topical NEOSH101 when applied twice daily to the balding scalp for 16 weeks One hundred eighty men with NorwoodHamilton grades III-IV with thinning in the top and center of the scalp will participate Three equally sized treatment groups 60 men each will receive either topical NEOSH101 20 minoxidil 5 or placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None